AIR METHODS Corp
Stock Symbol: AIRM
Air Methods Corporation (Air Methods) is a provider of air medical emergency transport services and systems throughout the United States. The Company provides air medical emergency transport services under two service delivery models: Community-Based Services (CBS) and Hospital-Based Services (HBS). As of December 31, 2010, the Company’s CBS Division provided air medical transportation services in 24 states, while its HBS Division provided air medical transportation services to hospitals located in 30 states under operating agreements with original terms ranging from 1to10 years. Under both CBS and HBS operations, it transports persons requiring intensive medical care from either the scene of an accident or general care hospitals to trauma centers or tertiary care centers. In August 2011, the Company acquired OF Air Holdings Corporation and its subsidiaries, including Omniflight Helicopters, Inc.
June 10 2015:
Wall Street analysts have placed a target price of $58.75 for Air Methods Corporation (NASDAQ:AIRM). This number is based on the mean consensus estimate from the 3 research firms that recently issued reports on the stock.
The average broker recommendation is arithmetical average of the individual ratings contributed by sell-side analysts to produce a Consensus Analyst Rating for each stock. On a scale of 1 to 5 where 1 is a Strong Buy and 5 is a Strong Sell, has the stock ranked 1.25 based on 3 broker recommendations. Of the 3 analysts who have issued estimates, the most bullish sees the stock reaching $61.25 within the next 12 months while the most conservative sees the stock at $57 within the year.
According to analysts, Air Methods Corporation (NASDAQ:AIRM) is expected to report earnings per share for the current fiscal quarter of $0.84. This is the consensus mean estimate based on the individual covering sell-side analysts’ reported numbers. The company last reported earnings for the period ending on 2015-03-31 of $0.36. The reported number was 0.02 away from the consensus estimate, or a surprise factor of 5.88 .
In looking at the long term growth prospects of the company, sell-side analysts have a consensus mean earnings per share estimate for the current year of $3.05. The high end estimate for this time frame is $3.26 with the low being $2.87.